Perspectives on Antibiotics and Tracking Symptoms in Children
Launched by MURDOCH CHILDRENS RESEARCH INSTITUTE · Jul 22, 2025
Trial Information
Current as of August 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study is looking at how families feel about and make decisions regarding how long children should take antibiotics when treated for common bacterial infections like urinary tract infections, skin infections, sore throats, ear infections, and chest infections. It focuses on children aged 4 to 17 who come to the Royal Children’s Hospital Emergency Department and are given antibiotics either by mouth or by IV (through a vein) at home before switching to oral antibiotics. The study also wants to see if using a Garmin Smartwatch and an app called WeGuide to track children’s symptoms is practical and easy for families to use.
Children who are eligible for this study are between 4 and 17 years old, have one of the listed infections, and have been prescribed oral antibiotics as part of their normal treatment. Parents or guardians need to agree to join by signing a consent form and must speak English to take part. If your child joins, you can expect to use the smartwatch and app to keep track of symptoms, and you’ll be asked to share your thoughts on the antibiotic treatment your child receives. This study hasn’t started recruiting yet, but it aims to help doctors and families better understand antibiotic use and symptom tracking in children with these infections.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Between the ages of ≥ 4 years and ≤ 17 years at enrolment.
- • Diagnosed with any of the following at RCH ED: urinary tract infection (UTI), cellulitis, impetigo, pharyngitis, tonsillitis, respiratory tract infections, otitis media.
- • Prescribed oral antibiotics (either immediately or as switch from IV antibiotics after transfer to HITH) as standard of care due to having uncomplicated infection as deemed by their treating doctor.
- • Parent/guardian provides a signed and dated informed consent form.
- Exclusion Criteria:
- • - Parent/guardian does not speak English
About Murdoch Childrens Research Institute
Murdoch Children's Research Institute (MCRI) is a leading pediatric research organization based in Australia, dedicated to improving child health through innovative research and clinical trials. With a focus on understanding and addressing the unique health challenges faced by children, MCRI collaborates with hospitals, universities, and community partners to translate research findings into practical solutions. The institute's multidisciplinary team of scientists, clinicians, and researchers is committed to advancing pediatric medicine and enhancing the quality of life for children and their families through groundbreaking studies and evidence-based interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Melbourne, Victoria, Australia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported